inflammatory breast neoplasms/progesterone

Länken sparas på Urklipp

Välj sorteringstyp

Sida 1 från 67 resultat

Effectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Inflammatory breast cancer (IBC) is the most aggressive form of primary breast cancer. METHODS A 40-year-old woman was referred to our hospital for evaluation of an induration in the right breast, suspected to be breast cancer. The tumor was diagnosed as estrogen receptor-negative,

[A Case Report of Luminal A Male Inflammatory Breast Cancer that Was Difficult to Treat Because of Trousseau Syndrome].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

This report describes the case of a 67-year-old male with inflammatory breast cancer. He had noticed a left breast mass about seven years previously, but he had ignored it. He then visited our hospital 4 months previously when multiple small masses occurred in the left front chest wall. The tumor

Inflammatory breast cancer: a single centre analysis.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer characterized by rapidly progressive breast erythema, pain and tenderness, oedema and paeu d'orange appearance. It accounts for 1-3% of all newly diagnosed cases of breast cancer in the west. Data on

(18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE The objective of this study was to evaluate the role of (18)F-FDG PET/CT in predicting overall survival in inflammatory breast cancer patients undergoing neoadjuvant chemotherapy. METHODS Included in this retrospective study were 53 patients with inflammatory breast cancer who had at least

[Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

From a series of 89 clinically inflammatory breast cancers, the authors settle a subgroup of tumors, the infiltrative ductal carcinomas with a pleomorphic structure. They have better histological and hormonal prognostic criteria than the other carcinomas, especially the infiltrative ductal

Case Report: Hormone Receptor Positive, HER2/neu Negative Inflammatory Breast Cancer in a Male Patient.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Inflammatory breast cancer is a rare and aggressive disease found almost exclusively in women. We present a case of a 51-year-old male with inflammatory breast carcinoma. The patient presented with a mass measuring roughly 7 cm with overlying erythema, peau d'orange appearance, and prominent nipple

Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We analyzed the role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy. Thirty-eight patients (estrogen receptor [ER] and/or progesterone receptor [PgR] >or=10% of the cells 21, premenopausal 14, Ki-67 expression

Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Pegylated liposomal doxorubicin (PLD) was shown as active but less toxic compared to doxorubicin in advanced breast cancer. Given its low cardiotoxicity, the combination of PLD and trastuzumab appears most attractive in the treatment of human epidermal factor receptor 2 (HER2)-positive

Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE Inflammatory breast cancer (IBC) is associated with very poor prognosis. The aims of this study are (a) to prospectively identify differential gene expression patterns associated with IBC and (b) to confirm these pathways using tissue arrays. METHODS For gene expression analysis, IBC

Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Inflammatory breast cancer (IBC) is a rare but aggressive type of breast carcinoma. Despite multimodality approaches, the clinical outcome of patients with IBC remains poor. Tumors arising from cancer stem cells (CSCs) are associated with drug resistance, tumor recurrence, and poor

Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE Inflammatory breast cancer (IBC) is a clinical staging based on history and physical findings. Dermal lymphatic invasion (DLI) can occur with or without IBC. We examine how these independently affect outcome in women treated with postmastectomy radiation. METHODS Four hundred thirty-two

Occult inflammatory breast cancer: review of clinical, mammographic, US and pathologic signs.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE To examine the clinical, radiologic and pathologic findings of occult inflammatory breast cancer (OIBC) in order to identify features useful for diagnosis. METHODS We retrospectively reviewed the records of 19 women with OIBC observed at our Department between 1992 and 2001. We analysed

Expression of androgen receptor in inflammatory breast cancer and its clinical relevance.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Inflammatory breast cancer (IBC) is characterized by an aggressive clinical course with early metastasis and frequent resistance to conventional therapies. Identifying a novel therapeutic approach may improve the prognosis for patients with IBC. Because androgen receptor (AR)-expressing

A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We report a case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a complete response to trastuzumab and paclitaxel treatment. A 37-year-old woman was referred to our hospital for right breast swelling with broad skin redness and right axillary

Molecular determinants of the inflammatory breast cancer phenotype.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Despite advances in multimodality treatment, inflammatory breast cancer (IBC) remains the most aggressive and lethal form of breast cancer. The use of primary human IBC cell lines and functional in vive xenograft cancer models have revealed characteristics innate to IBC thought to confer a strong

Tidigare
1
2
3
4
5
Nästa

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning